1. Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index
by Chor-Sang Chim, Shing-Yan Ma, Wing-Yan Au, Carolyn Choy, Albert K. W. Lie, Raymond Liang, Chun-Chung Yau, and Yok-Lam Kwong
Blood
Volume 103(1):
January 1, 2004
©2004 by American Society of Hematology

2. Overall treatment results of nasal NK cell lymphoma.
Overall treatment results of nasal NK cell lymphoma. (A) OS (n = 67). (B) DFS for CR patients (n = 43).
Chor-Sang Chim et al. Blood 2004;103:
©2004 by American Society of Hematology

3. OS of patients showing a significance difference (P =
OS of patients showing a significance difference (P = .03) in favor of RT. .
OS of patients showing a significance difference (P = .03) in favor of RT.
Chor-Sang Chim et al. Blood 2004;103:
©2004 by American Society of Hematology

4. Prognostic impact of IPI. (A) Treatment with intensive chemotherapy.
Prognostic impact of IPI. (A) Treatment with intensive chemotherapy. Patients with an IPI less than or equal to 1 showed significantly better 10-year OS (P = .003). (B) Treatment with either RT or intensive chemotherapy. Patients with an IPI less than or equal to 1 still showed significantly better 20-year OS (P = .01).
Chor-Sang Chim et al. Blood 2004;103:
©2004 by American Society of Hematology